Cover Image

Letter: FIT ‐Based Triage for Symptomatic Colonoscopy‐Diagnostic Yield Is Not the Same as Pathway Safety

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Stjepan Škudar
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real‐World Performance of FIT Triage for Symptomatic Colonoscopy: Analysis of the UK National Endoscopy Database ( NED )
by: David Beaton, et al.
Published: (2026)

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis
by: Colin W. Howden, et al.
Published: (2024)

Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story?
by: Liang Jiao, et al.
Published: (2026)

Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story? Authors' Reply
by: Sanjay K. Murthy
Published: (2026)

Editorial: Good Vibrations for Better Colonoscopy Preparation and Constipation
by: Benjamin Kalivas, et al.
Published: (2025)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease
by: Jiahao Liu, et al.
Published: (2026)

Editorial: Surveillance Colonoscopy for Detection of Neoplasia in Inflammatory Bowel Disease—Is Dye‐Based Chromoendoscopy Always the Final Answer?
by: Andrea Cassinotti, et al.
Published: (2025)

Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence
by: Priyadarshini Zula, et al.
Published: (2026)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease. Authors' Reply
by: Walter W. Chan, et al.
Published: (2026)

Letter: From Safety to Precision—Optimising the Use of GLP‐1 Receptor Agonists in Gastroenterology
by: Joëlle St‐Pierre, et al.
Published: (2026)

Editorial: Right‐Sizing Colonoscopy Referrals for Patients With Possible Signs and Symptoms of Colorectal Cancer
by: Nicole P. Mirabadi, et al.
Published: (2025)

Letter: Balancing Cost and Consequence of Colon Capsule Endoscopy in Colorectal Cancer Pathways—Finding the Sweet Spot
by: Ian Io Lei, et al.
Published: (2025)

Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative Analyses of Randomised Trials
by: Hermann Brenner, et al.
Published: (2025)

Editorial: Metabolic Dysfunction and Alcohol—Two Sides of the Same Coin
by: Gustavo Ayares, et al.
Published: (2024)

Letter: Safety and Tolerability of Injectable Extended Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease
by: Xing Bai, et al.
Published: (2025)

Letter: Enhancing HCC Surveillance– GES Score Represents an Innovative Simple Effective Tool for Risk Stratification, Patient Safety and Reduced Anxiety
by: Ibrahima Gueye
Published: (2025)

Letter: Addressing Gaps in Hospital‐Based Hepatitis C Screening—Insights and Recommendations
by: Zhen Deng, et al.
Published: (2025)

Letter: Safety and Tolerability of Injectable Extended‐Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease—Authors' Reply
by: Luis Antonio Díaz, et al.
Published: (2025)

Letter: Enhancing HCC Surveillance: GES Score Represents an Innovative Simple Effective Tool for Risk Stratification, Patient Safety and Reduced Anxiety—Authors' Reply
by: Gamal Shiha, et al.
Published: (2025)

Letter: Addressing Gaps in Hospital‐Based Hepatitis C Screening—Insights and Recommendations. Authors' Reply'
by: Alberto Ferrarese, et al.
Published: (2025)

Letter: Intestinal Ultrasound‐Prioritising Progress
by: Kacie H. Denton, et al.
Published: (2026)

Letter: Irritable bowel syndrome and antibiotics
by: George F. Longstreth
Published: (2024)

Letter: Increased Prevalence of Visceral Obesity in Nonresponder Patients With Primary Biliary Cholangitis Based on Computed Tomography
by: Bo Li, et al.
Published: (2024)

Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation
by: Vlasios Gourgiotis, et al.
Published: (2025)

Letter: Steroid Tapering—Is Shorter Duration Better?
by: Juntao Lu, et al.
Published: (2026)

Letter: Resmetirom for treatment of MASH with children and adolescents
by: Yong‐Hai Zhou, et al.
Published: (2024)

Letter on “Efficacy and Safety of Tenofovir Alafenamide ( TAF ) and Tenofovir Disoproxil Fumarate ( TDF ) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment”
by: Yan Liu, et al.
Published: (2025)

Letter: Therapeutic Targeting of PPARs in PBC —Additional Considerations
by: Christophe Corpechot
Published: (2026)

Letter: Temporal Trends in the Rate of Colectomy in Ulcerative Colitis
by: Richard Pollok
Published: (2025)

Letter: Helicobacter pylori and Eosinophilic Oesophagitis—Lost in Definition?
by: Fernanda Cristofori, et al.
Published: (2025)

Letter: Irritable bowel syndrome and antibiotics—Authors' reply
by: Kyle Staller, et al.
Published: (2024)

Letter: Toward Intra‐Class Switching With JAK Inhibitors?
by: Mathieu Uzzan, et al.
Published: (2025)

Letter: Predictors of Corticosteroid Response in Alcohol‐Related Hepatitis
by: Ewan Forrest, et al.
Published: (2025)

Letter: The enigma of angiotensin receptor blocker‐associated enteropathy
by: Mustafa Mohamedrashed, et al.
Published: (2024)

Letter: Bowel Preparation Quality in Patients With Crohn's Disease
by: Tamar Schildkraut, et al.
Published: (2024)

Letter: Increased Prevalence of Visceral Obesity in Nonresponder Patients With Primary Biliary Cholangitis Based on Computed Tomography—Authors' Reply
by: Conrado Fernandez‐Rodriguez, et al.
Published: (2024)

Letters on “Efficacy and Safety of Tenofovir Alafenamide ( TAF ) and Tenofovir Disoproxil Fumarate ( TDF ) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.” Authors' Reply
by: Grace Lai‐Hung Wong, et al.
Published: (2025)

Letter: Geographic Transportability of Shingles Risk With Advanced IBD Therapies
by: Guofu Mao, et al.
Published: (2026)

Letter: The Unresolved Issue of NSBB Confounding in Statin Research for Cirrhosis
by: Deliang Huang, et al.
Published: (2026)

Letter: Risks of proton pump inhibitor treatment in cirrhotic patients
by: Jiamei Wang, et al.
Published: (2024)